- Trials with a EudraCT protocol (8)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9)
8 result(s) found for: Tensin.
Displaying page 1 of 1.
EudraCT Number: 2008-003988-39 | Sponsor Protocol Number: VA 2008/34 | Start Date*: 2008-11-19 | |||||||||||
Sponsor Name:Centre Régional de Lutte contre le Cancer Val d'Aurelle- Paul Lamarque | |||||||||||||
Full Title: Essai de phase I-II évaluant l’association de Cetuximab et de Trastuzumab chez des patients atteints de cancer pancréatique métastatique ayant progressé sous chimiothérapie à base de gemcitabine (E... | |||||||||||||
Medical condition: Adénocarcinome pancréatique métastatique histologiquement confirmé en progression et ayant reçu une chimiothérapie à base de Gemcitabine. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002637-11 | Sponsor Protocol Number: CBYL719H12301 | Start Date*: 2020-03-18 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: EPIK-B3: A Phase III, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of alpelisib (BYL719) in combination with nab-paclitaxel in patients with adv... | ||
Medical condition: Advanced triple negative breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) FR (Completed) SK (Completed) DE (Completed) GB (GB - no longer in EU/EEA) IT (Completed) NO (Completed) AT (Completed) BG (Completed) SI (Completed) PL (Completed) HR (Completed) GR (Completed) RO (Completed) PT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004429-17 | Sponsor Protocol Number: CO39303 | Start Date*: 2018-09-19 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL TESTING IPATASERTIB PLUS ABIRATERONE PLUS PREDNISONE/PREDNISOLONE, RELATIVE TO PLACEBO PLUS ABIRATERONE PLUS PREDNISONE/... | |||||||||||||
Medical condition: Metastatic Castrate-Resistant Prostate Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: NO (Completed) PT (Completed) DE (Completed) DK (Completed) HU (Completed) GB (GB - no longer in EU/EEA) AT (Completed) IE (Completed) BE (Completed) ES (Ongoing) GR (Completed) PL (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-016875-30 | Sponsor Protocol Number: VA 2009/40 | Start Date*: 2010-04-12 | |||||||||||
Sponsor Name:CRLC VAL D’AURELLE | |||||||||||||
Full Title: Essai de phase II évaluant l’association de gemcitabine, trastuzumab et erlotinib en 1ère ligne de traitement par chimiothérapie des patients atteints d’un adénocarcinome du pancréas métastatique | |||||||||||||
Medical condition: adénocarcinome du pancréas métastatique | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-000346-33 | Sponsor Protocol Number: D361BC00001 | Start Date*: 2020-07-20 |
Sponsor Name:AstraZeneca AB | ||
Full Title: Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing Efficacy and Safety of Capivasertib+Abiraterone Versus Placebo+Abiraterone as Treatment for Patients with DeNovo Metastatic Ho... | ||
Medical condition: Metastatic Hormone-Sensitive Prostate Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Trial now transitioned) BG (Trial now transitioned) CZ (Trial now transitioned) GB (GB - no longer in EU/EEA) SK (Trial now transitioned) BE (Trial now transitioned) PL (Trial now transitioned) DE (Trial now transitioned) FR (Trial now transitioned) AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004648-44 | Sponsor Protocol Number: MedOPP253 | Start Date*: 2020-07-06 | ||||||||||||||||||||||||||
Sponsor Name:Medica Scientia Innovation Research S.L (MEDSIR) | ||||||||||||||||||||||||||||
Full Title: A multicentre, Open-Label, Non-comparative, three-arm, phase IIa trial of Ipatasertib (GDC-0068) in Combination with non-Taxane chemotherapy agents for taxane-pre... | ||||||||||||||||||||||||||||
Medical condition: UNRESECTABLE LOCALLY ADVANCED OR METASTATIC RIPLE-NEGATIVE BREAST CANCER PATIENTS | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||||||||||||
Trial protocol: PT (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001398-30 | Sponsor Protocol Number: MEDOPP437 | Start Date*: 2023-05-08 |
Sponsor Name:Medica Scientia Innovation Research, S.L. | ||
Full Title: PHASE II STUDY FOR PIK3CA/PTEN-ALTERED ADVANCED METAPLASTIC BREAST CANCER TREATED WITH MEN1611 MONOTHERAPY OR IN COMBINATION WITH ERIBULIN -THE SABINA STUDY- English PHASE II STUDY WITH MEN1611 M... | ||
Medical condition: Hormone Receptor (HR)-known/ Human Epidermial Growth Factor Receptor 2 (HER2)-negative, phosphatidylinositol-4,5-bisphosphate 3kinase catalytic subunit alpha (PIK3CA)/ Phosphatase and Tensin Homolo... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004977-23 | Sponsor Protocol Number: DP312804 | Start Date*: 2013-04-25 | |||||||||||
Sponsor Name:SFJ LungCancer, Ltd. | |||||||||||||
Full Title: ARCHER 1050: A RANDOMIZED, OPEN-LABEL, PHASE 3, EFFICACY AND SAFETY STUDY OF DACOMITINIB (PF 00299804) VERSUS GEFITINIB FOR THE FIRST LINE TREATMENT OF LOCALLY ADVANCED OR METASTATIC NON SMALL CELL... | |||||||||||||
Medical condition: Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
